Short answer
U S PHYSICAL THERAPY INC /NV (USPH) filed an 8-K current report with the SEC on August 12, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Updated investor presentation released August 12, 2026, providing refreshed company overview and investor messaging.
U S PHYSICAL THERAPY INC /NV 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Updated investor presentation released August 12, 2026, providing refreshed company overview and investor messaging
- Exhibit 99.1 contains presentation details, with additional access through USPH’s Investor Relations website
- Disclosure furnished under Regulation FD, not treated as filed under Exchange Act Section 18 or incorporated into registration statements
Item EX-99.1 · Exhibit EX-99.1
- TTM revenue $812M and Adjusted EBITDA $96M through June 30, 2026, indicating substantial operating scale
- 796 owned or managed locations across 45 states as of July 31, 2026, reinforcing national consolidation platform
- Revenue grew 8% year over year, supported by organic clinic expansion and acquisitions
- $25M share-repurchase program active, including 306,256 shares repurchased for $19.2M in 2Q26
- Credit facility increased from $325M to $450M, extending maturity to April 14, 2031 and supporting acquisition flexibility
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other U S PHYSICAL THERAPY INC /NV 8-K filings
Get the next USPH 8-K as it lands
Follow USPH for push alerts, or ask the research agent what this filing means.